Ameriprise
HQL

Ameriprise’s abrdn Life Sciences Investors HQL Stock Holding History

Ameriprise’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.11M Buy
191,761
+1,113
+0.6% +$18.6K ﹤0.01% 2735
2025
Q4 		$3.2M Sell
190,648
-19,033
-9% -$320K ﹤0.01% 2744
2025
Q3 		$3.25M Buy
209,681
+41,255
+24% +$565K ﹤0.01% 2724
2025
Q2 		$2.17M Buy
168,426
+101
+0.1% +$1.25K ﹤0.01% 2909
2025
Q1 		$2.14M Buy
168,325
+14,929
+10% +$202K ﹤0.01% 2862
2024
Q4 		$2M Buy
153,396
+10,742
+8% +$155K ﹤0.01% 2926
2024
Q3 		$2.15M Sell
142,654
-11,323
-7% -$171K ﹤0.01% 2879
2024
Q2 		$2.18M Buy
153,977
+3,757
+3% +$50.8K ﹤0.01% 2821
2024
Q1 		$2.05M Buy
150,220
+23,245
+18% +$322K ﹤0.01% 2861
2023
Q4 		$1.71M Buy
126,975
+9,300
+8% +$114K ﹤0.01% 2944
2023
Q3 		$1.47M Sell
117,675
-15,753
-12% -$207K ﹤0.01% 2975
2023
Q2 		$1.81M Sell
133,428
-2,340
-2% -$32.3K ﹤0.01% 2926
2023
Q1 		$1.89M Buy
135,768
+15,196
+13% +$217K ﹤0.01% 2874
2022
Q4 		$1.73M Buy
120,572
+21,710
+22% +$315K ﹤0.01% 2871
2022
Q3 		$1.35M Buy
98,862
+3,051
+3% +$45.6K ﹤0.01% 2973
2022
Q2 		$1.36M Buy
95,811
+22,566
+31% +$341K ﹤0.01% 2984
2022
Q1 		$1.21M Buy
73,245
+4,485
+7% +$77.2K ﹤0.01% 3129
2021
Q4 		$1.32M Buy
68,760
+3,177
+5% +$63.9K ﹤0.01% 3130
2021
Q3 		$1.37M Buy
65,583
+13,890
+27% +$297K ﹤0.01% 3024
2021
Q2 		$1.12M Sell
51,693
-40,163
-44% -$811K ﹤0.01% 3181
2021
Q1 		$1.81M Buy
91,856
+3,517
+4% +$72.5K ﹤0.01% 2891
2020
Q4 		$1.74M Buy
88,339
+23,966
+37% +$443K ﹤0.01% 2863
2020
Q3 		$1.14M Buy
64,373
+37,186
+137% +$666K ﹤0.01% 2915
2020
Q2 		$490K Buy
27,187
+2,564
+10% +$44K ﹤0.01% 3204
2020
Q1 		$369K Sell
24,623
-3,790
-13% -$62.1K ﹤0.01% 3232
2019
Q4 		$495K Buy
28,413
+12,965
+84% +$213K ﹤0.01% 3331
2019
Q3 		$233K Sell
15,448
-2,752
-15% -$44.1K ﹤0.01% 3511
2019
Q2 		$307K Buy
18,200
+498
+3% +$8.2K ﹤0.01% 3480
2019
Q1 		$303K Sell
17,702
-106
-0.6% -$1.83K ﹤0.01% 3447
2018
Q4 		$269K Buy
17,808
+18
+0.1% +$317 ﹤0.01% 3382
2018
Q3 		$363K Sell
17,790
-1,419
-7% -$28.2K ﹤0.01% 3395
2018
Q2 		$361K Sell
19,209
-3,130
-14% -$58.9K ﹤0.01% 3345
2018
Q1 		$429K Sell
22,339
-1,293
-5% -$25.9K ﹤0.01% 3254
2017
Q4 		$471K Buy
23,632
+3,737
+19% +$74.8K ﹤0.01% 3225
2017
Q3 		$425K Sell
19,895
-64
-0.3% -$1.36K ﹤0.01% 3277
2017
Q2 		$416K Buy
19,959
+3,828
+24% +$77.4K ﹤0.01% 3306
2017
Q1 		$313K Buy
16,131
+1,427
+10% +$26.4K ﹤0.01% 3328
2016
Q4 		$251K Buy
14,704
+731
+5% +$12.8K ﹤0.01% 3567
2016
Q3 		$262K Sell
13,973
-701
-5% -$13.2K ﹤0.01% 3463
2016
Q2 		$252K Buy
14,674
+577
+4% +$10.6K ﹤0.01% 3451
2016
Q1 		$253K Sell
14,097
-1,746
-11% -$31.7K ﹤0.01% 3440
2015
Q4 		$370K Buy
15,843
+2,730
+21% +$67.7K ﹤0.01% 3397
2015
Q3 		$295K Buy
13,113
+3,489
+36% +$97.7K ﹤0.01% 3486
2015
Q2 		$271K Buy
9,624
+2,193
+30% +$60.8K ﹤0.01% 3695
2015
Q1 		$205K Sell
7,431
-796
-10% -$21.7K ﹤0.01% 3583
2014
Q4 		$205K Sell
8,227
-965
-10% -$23.2K ﹤0.01% 3494
2014
Q3 		$203K Sell
9,192
-1,171
-11% -$25.4K ﹤0.01% 3394
2014
Q2 		$215K Buy
10,363
+1,541
+17% +$32.3K ﹤0.01% 3297
2014
Q1 		$192K Sell
8,822
-154
-2% -$3.43K ﹤0.01% 3257
2013
Q4 		$183K Buy
8,976
+4,083
+83% +$79.2K ﹤0.01% 3178
2013
Q3 		$94K Sell
4,893
-2,004
-29% -$38.4K ﹤0.01% 3488
2013
Q2 		$123K Buy
+6,897
New +$125K ﹤0.01% 3295

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

Ameriprise's HQL Position: Q1 2026 in Review

Ameriprise increased its abrdn Life Sciences Investors (HQL) stake by 0.58% in Q1 2026, buying an estimated $18.6K and bringing the position to 191,761 shares worth $3.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2735.

Ameriprise first reported a position in HQL in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.25M in Q3 2025. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

  • Ameriprise held 191,761 shares of abrdn Life Sciences Investors worth $3.11M as of Q1 2026.
  • Ameriprise bought 1,113 abrdn Life Sciences Investors shares in Q1 2026, an estimated $18.6K.
  • abrdn Life Sciences Investors made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #2735 holding.
  • Ameriprise first reported a position in abrdn Life Sciences Investors in Q2 2013 and has held it in 52 quarters since.
  • Ameriprise's abrdn Life Sciences Investors position peaked at $3.25M in Q3 2025.
  • 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.